rB/HPIV3 vaccine

recombinant bovine/human parainfluenza virus type 3 vaccine (rB/HPIV3) · National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rB/HPIV3 vaccine, covering 2012-03-01 to 2012-03-01. Get the full timeline:

Most recent: Clinical Trial Update: Safety of and Immune Response to a Cow/Human Parainfluenza Virus Vaccine (rB/HPIV3) in Healthy Infants, Children, and Adults [Phase 1]

See pricing